Human CKAP4 ELISA Kit (V2LY-0626-LY4211)

Luo, T., Ding, K., Ji, J., Zhang, X., Yang, X., Chen, A., ... & Li, X. (2021). Cytoskeleton-associated protein 4 (CKAP4) promotes malignant progression of human gliomas through inhibition of the Hippo signaling pathway. Journal of Neuro-Oncology, 154(3), 275-283.

Wang, Y., Yu, H., Xie, X., Deng, T., Ye, L., Wu, L., ... & Chen, G. (2021). Plasmalemma vesicle-associated protein promotes angiogenesis in cholangiocarcinoma via the DKK1/CKAP4/PI3K signaling pathway. Oncogene, 1-14.

Li, S. X., Li, J., Dong, L. W., & Guo, Z. Y. (2020). Cytoskeleton-associated protein 4, a promising biomarker for tumor diagnosis and therapy. Frontiers in Molecular Biosciences, 7.

Chen, Z. Y., Wang, T., Gan, X., Chen, S. H., He, Y. T., Wang, Y. Q., & Zhang, K. H. (2020). Cytoskeleton-associated membrane protein 4 is upregulated in tumor tissues and is associated with clinicopathological characteristics and prognosis in hepatocellular carcinoma. Oncology letters, 19(6), 3889-3898.

Wang, Y., Yu, W., He, M., Huang, Y., Wang, M., & Zhu, J. (2019). Serum cytoskeleton-associated protein 4 as a biomarker for the diagnosis of hepatocellular carcinoma. OncoTargets and therapy, 12, 359.

Chen, L., You, C., Jin, X., Zhou, L., Huang, L., & Wang, Y. (2018). Cytoskeleton-associated protein 4 is a novel serodiagnostic marker for esophageal squamous-cell carcinoma. OncoTargets and therapy, 11, 8221.

Yanagita, K., Nagashio, R., Jiang, S. X., Kuchitsu, Y., Hachimura, K., Ichinoe, M., ... & Sato, Y. (2018). Cytoskeleton-associated protein 4 is a novel serodiagnostic marker for lung cancer. The American journal of pathology, 188(6), 1328-1333.

Gladka, M. M., Molenaar, B., De Ruiter, H., Van Der Elst, S., Tsui, H., Versteeg, D., ... & Van Rooij, E. (2018). Single-cell sequencing of the healthy and diseased heart reveals cytoskeleton-associated protein 4 as a new modulator of fibroblasts activation. Circulation, 138(2), 166-180.

Kikuchi, A., Fumoto, K., & Kimura, H. (2017). The Dickkopf1‐cytoskeleton‐associated protein 4 axis creates a novel signalling pathway and may represent a molecular target for cancer therapy. British journal of pharmacology, 174(24), 4651-4665.

Chavda, B., Ling, J., Majernick, T., & Planey, S. L. (2017). Antiproliferative factor (APF) binds specifically to sites within the cytoskeleton-associated protein 4 (CKAP4) extracellular domain. BMC biochemistry, 18(1), 1-14.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols